Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice

Neha J Pagidipati; Anne Hellkamp; Laine Thomas; Martha Gulati; Eric D Peterson; Tracy Y Wang

doi:10.1001/jamacardio.2017.2369

Use of Prescription Smoking Cessation Medications After Myocardial Infarction Among Older Patients in Community Practice

JAMA Cardiol. 2017 Sep 1;2(9):1040-1042. doi: 10.1001/jamacardio.2017.2369.

Authors

Neha J Pagidipati¹, Anne Hellkamp¹, Laine Thomas¹, Martha Gulati², Eric D Peterson¹, Tracy Y Wang¹

Affiliations

¹ Duke Clinical Research Institute, Duke University, Durham, North Carolina.
² University of Arizona College of Medicine, Phoenix.

Abstract

This population-based study uses the Acute Coronary Treatment and Intervention Outcomes Network Registry to evaluate the prevalence of smoking cessation medication use among patients following myocardial infarction.

MeSH terms

Age Factors
Aged
Bupropion / therapeutic use*
Comorbidity
Female
Humans
Lung Diseases / epidemiology
Male
Multivariate Analysis
Myocardial Infarction / epidemiology
Myocardial Infarction / therapy*
Odds Ratio
Peripheral Arterial Disease / epidemiology
Secondary Prevention
Sex Factors
Smoking Cessation / methods*
Smoking Cessation Agents / therapeutic use*
Varenicline / therapeutic use*

Substances

Smoking Cessation Agents
Bupropion
Varenicline